Date published: 2026-6-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

CHCHD2 Lentiviral Activation Particles (h2): sc-412127-LAC-2

0.0(0)
Write a reviewAsk a question

Datasheets
  • Target species: human
  • 200 µl of transduction-ready, high-titer CRISPR/dCas9 Lentiviral Activation Particles
  • CHCHD2 Lentiviral Activation Particles (h2) is a synergistic activation mediator (SAM) transcription activation system designed to specifically and efficiently upregulate gene expression via lentiviral transduction of cells
  • CHCHD2 Lentiviral Activation Particles (h2) contain the following SAM Activation elements: a deactivated Cas9 (dCas9) nuclease (D10A and N863A) fused to the transactivation domain VP64, an MS2-p65-HSF1 fusion protein and a target-specific 20 nt guide RNA. They also contain the blasticidin, hygromycin and puromycin resistance genes
  • Upon transduction, the SAM complex binds to a site-specific region approximately 200-250 nt upstream of the transcriptional start site and provides robust recruitment of transcription factors for highly efficient gene activation
  • gRNAs encoded by CHCHD2 Lentiviral Activation Plasmid (h2) and CHCHD2 Lentiviral Activation Plasmid (h22) target distinct regulatory regions of the CHCHD2 promoter. One or both designs may be available
    Gene Editing Promo Banner

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    CHCHD2 Lentiviral Activation Particles (h2)

    sc-412127-LAC-2
    200 µl
    $455.00